Publications of Larysa Teplytska
All genres
Journal Article (20)
1.
Journal Article
12 (2), 244 (2022)
Multi-Omics Analysis Reveals Myelin, Presynaptic and Nicotinate Alterations in the Hippocampus of G72/G30 Transgenic Mice. JOURNAL OF PERSONALIZED MEDICINE 2.
Journal Article
11 (2), 128 (2021)
Y Behavioral and Metabolome Differences between C57BL/6 and DBA/2 Mouse Strains: Implications for Their Use as Models for Depression- and Anxiety-Like Phenotypes. METABOLITES 3.
Journal Article
27 (4), pp. 2580 - 2591 (2017)
Tau Deletion Prevents Stress-Induced Dendritic Atrophy in Prefrontal Cortex: Role of Synaptic Mitochondria. CEREBRAL CORTEX 4.
Journal Article
7, 15788 (2017)
Ketamine's antidepressant effect is mediated by energy metabolism and antioxidant defense system. SCIENTIFIC REPORTS 5.
Journal Article
41 (7), pp. 1751 - 1758 (2016)
Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo. NEUROPSYCHOPHARMACOLOGY 6.
Journal Article
10 (12), pp. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. Proteomics. Clinical applications 7.
Journal Article
10 (12), pp. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. SI 8.
Journal Article
58, pp. 115 - 122 (2014)
Behavioral extremes of trait anxiety in mice are characterized by distinct metabolic profiles. JOURNAL OF PSYCHIATRIC RESEARCH 9.
Journal Article
46 (10), pp. 1359 - 1365 (2012)
Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. Journal of Psychiatric Research 10.
Journal Article
37 (4), pp. 1013 - 1025 (2012)
Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology. Neuropsychopharmacology 11.
Journal Article
70 (11), pp. 1074 - 1082 (2011)
Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways. Biological Psychiatry 12.
Journal Article
44 (6), p. 289 - 289 (2011)
Anxiety and mitochondria: Insights from the -omics world. Pharmacopsychiatry 13.
Journal Article
44 (6), p. 289 - 289 (2011)
Proteomic alterations in G72/G30 transgenic mice. Pharmacopsychiatry 14.
Journal Article
15 (7), pp. 702 - 711 (2010)
Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways. Molecular Psychiatry 15.
Journal Article
31 (8), pp. 1294 - 1301 (2010)
Profiling of mouse synaptosome proteome and phosphoproteome by IEF. Electrophoresis 16.
Journal Article
42 (5), pp. 215 - 216 (2009)
Proteomic genotyping in a mouse model of trait anxiety exposes disease relevant pathways. Pharmacopsychiatry 17.
Journal Article
42 (5), p. 217 - 217 (2009)
Stable isotope metabolic labeling of a mouse model reveals synaptic biomarkers for anxiety disorders. Pharmacopsychiatry 18.
Journal Article
5 (10), pp. 1914 - 1920 (2006)
Protein biomarkers in a mouse model of extremes in trait anxiety. Molecular & Cellular Proteomics 19.
Journal Article
27, pp. 4585 - 4595 (2006)
Phosphopeptide enrichments by IEF. Electrophoresis 20.
Journal Article
52 (Supplement), pp. 231 - 235 (2005)
The quest for brain disorder biomarkers. The Journal of Medical Investigation